Notice: This company has been marked as potentially delisted and may not be actively trading. AgeX Therapeutics (AGE) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Serina Therapeutics Inc (SER)November 7, 2024 | investing.comGlobal Clinical Laboratory Service Market to Cross ~USD 400 Billion Mark by 2030 | DelveInsightOctober 17, 2024 | finance.yahoo.comSerina Therapeutics to Present at the 14th Annual Injectables SummitOctober 2, 2024 | markets.businessinsider.comRussell Skibsted's Net WorthSeptember 10, 2024 | benzinga.comSerina Therapeutics, Inc. (SER)August 18, 2024 | finance.yahoo.comBillionaires are betting on anti-ageing research, but can ageing really be cured?August 16, 2024 | finance.yahoo.comGLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 23, 2024 | finance.yahoo.comSER Serina Therapeutics, Inc.May 18, 2024 | seekingalpha.comStem Cell Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 162 Agreements Signed Since 2016May 7, 2024 | finance.yahoo.comSerina Therapeutics Announces Completion of Merger with AgeX TherapeuticsMarch 26, 2024 | globenewswire.comAgeX Therapeutics, Inc.: AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsMarch 23, 2024 | finanznachrichten.deAgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsMarch 22, 2024 | globenewswire.comAgeX Therapeutics (NYSE:AGE) Sees Unusually-High Trading VolumeAgeX Therapeutics (NYSE:AGE) Sees Strong Trading VolumeMarch 18, 2024 | marketbeat.comAgeX Therapeutics (NYSE:AGE) Reaches New 12-Month High at $17.42AgeX Therapeutics (NYSE:AGE) Sets New 1-Year High at $17.42March 15, 2024 | marketbeat.comAGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGEFebruary 27, 2024 | businesswire.comAgeX Therapeutics Secures $500K Convertible Note DealFebruary 7, 2024 | msn.comAgeX Therapeutics Expands Ties with JuvVentures Equity DealFebruary 7, 2024 | msn.comWhy IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving PremarketJanuary 25, 2024 | msn.comAgeX Therapeutics Inc AGEDecember 13, 2023 | morningstar.comWhat's Going On With Penny Stock AgeX Therapeutics?November 17, 2023 | msn.comSerina Therapeutics Announces POZ Polymer Technology License Agreement with PfizerNovember 17, 2023 | finance.yahoo.comAgeX Therapeutics GAAP EPS of -$0.14, revenue of $0.06MNovember 14, 2023 | msn.comAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comObesity Pipeline | Clinical Trials, Key Companies – Aardvark, Adocia, Agentix AgeX TherapeuticsNovember 6, 2023 | benzinga.comSerina Therapeutics to merge with subsidiary of AgeXAugust 31, 2023 | msn.comShareholder Alert: Ademi LLP investigates whether AgeX Therapeutics, Inc. has obtained a Fair Price in its transaction with SerinaAugust 30, 2023 | benzinga.comSerina Therapeutics and Agex Therapeutics enter merger agreementAugust 30, 2023 | seekingalpha.comAgeX Therapeutics Shares Rise Premarket on Reverse Merger Deal >AGEAugust 30, 2023 | marketwatch.comSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAugust 30, 2023 | finance.yahoo.comAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockJuly 24, 2023 | finance.yahoo.comAgeX issues preferred stock to Juvenescence to nix $36M debtJuly 21, 2023 | seekingalpha.com25 States with the Highest Life Expectancy in the USJune 28, 2023 | finance.yahoo.comNYSE American to Suspend Trading Immediately in AgeX Therapeutics, Inc. (AGE) and Commence Delisting ProceedingsMay 17, 2023 | finance.yahoo.comCORRECTING and REPLACING NYSE American to Commence Delisting Proceedings Against AgeX Therapeutics, Inc. (AGE)May 17, 2023 | businesswire.comAgeX Therapeutics GAAP EPS of -$0.09, revenue of $0.01MMay 12, 2023 | seekingalpha.comAgeX Therapeutics Says Projected Cash Flows Raise Going Concern DoubtsMay 12, 2023 | marketwatch.comAgeX Therapeutics Reports First Quarter 2023 Financial ResultsMay 12, 2023 | finance.yahoo.comAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsMarch 31, 2023 | finance.yahoo.comAGE AgeX Therapeutics, Inc.March 30, 2023 | seekingalpha.comTonix starts enrollment in mid-stage study of depression drug TNX-601 ERMarch 16, 2023 | msn.comAgeX Therapeutics gets $10M loan ahead of potential restructuringMarch 16, 2023 | msn.comJuvenescence Now Owns 75.60% of AgeX TherapeuticsFebruary 21, 2023 | 247wallst.comAnti-Senescence Therapy Market Industry Analysis Database for Period from 2023-2028February 13, 2023 | marketwatch.comWith 7.8% CAGR, Longevity and Anti-senescence Therapy Market to Witness A Pronounce Growth During 2023-2028 | 87 Pages ReportDecember 22, 2022 | marketwatch.comLongevity and Anti-senescence Therapy Market 2023 Expected to Reach Significant Rate by 2028December 2, 2022 | marketwatch.comAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsNovember 25, 2022 | finance.yahoo.comAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsNovember 10, 2022 | finance.yahoo.comLongevity and Anti-senescence Therapy Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028October 12, 2022 | marketwatch.comAgeX Therapeutics, Inc. (AGE)September 12, 2022 | finance.yahoo.com Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address 50-year Wall Street legend: “Sell this tech stock NOW” (Ad)Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. AGE Media Mentions By Week AGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGE News Sentiment▼0.550.49▲Average Medical News Sentiment AGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGE Articles This Week▼00▲AGE Articles Average Week Get AgeX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CALC News IMMX News ATNM News VTVT News SCYX News VRCA News IOBT News FBIO News GANX News VYNE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGE) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AgeX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AgeX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
